Thomson Medical (SGX:A50) narrowed its attributable loss to owners to SG$10.2 million in the fiscal first half ended Dec. 31, 2025, from SG$12.9 million a year earlier, according to a Wednesday filing with the Singapore Exchange.
Loss per share narrowed to SG$0.00039 from SG$0.00049 a year ago.
Revenue jumped 7% year over year to SG$213.1 million from SG$199.1 million.